Skip to main content
. 2022 Aug 26;14(17):4134. doi: 10.3390/cancers14174134

Figure 2.

Figure 2

Differences between B16F10-NR tumour and B16F10-R tumour cells. (A) PD-L1 expression on the surface of B16F10-NR and B16F10-R cells. (B) Gating strategy to identify intratumoural T and NK cells. (C) Differences in the number of infiltrating lymphocytes in the TME of B16F10-NR tumours and B16F10-R tumours (one-way ANOVA test, Tukey); ns, not statistically significant; *** p < 0.001; **** p < 0.0001.